eli lilly oral tirzepatide weight loss drug data released Foundayo: The newest weight loss
Description
A new commentary published in Diabetes, Obesity and Metabolism shares practical recommendations for gathering real world evidence on the use of GLP-1 medications in people with Prader-Willi syndrome
Learn the risks of grey market tirzepatide, from contamination to dosing errors
The FDA urges healthcare professionals to stop administering the products, and patients should stop using them.
Are there any dietary considerations when taking GLP-1 medications
